Furthermore, IRE1/XBP1 ablation in tumor cDC1s controls a discrete set of genes related to proteostatic programs without altering pro-tumorigenic programs seen in other tumor myeloid cell subsets (26–28). This evidence concerns the gene ERN1 and neoplasm.